Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

CAR-T Cell Therapy Market Review and Forecast 2018-2024: Market Size, Share, Trends, Issues and Recent Developments - ResearchAndMarkets.com

January 31, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 31, 2020--

The “CAR-T Cell Therapy Market Review” report has been added to ResearchAndMarkets.com’s offering.

CAR-T Cell Therapy Market Review discusses CAR-T’s impressive revenue growth, which is expected to continue given the effectiveness of the therapy and the projected new users. There are positive factors for the market, though there are limits to growth. Patient volume should increase, though it is likely that the unusually large prices will not sustain over the next five years.

The report provides the following market data:

The report discusses CAR-T therapy market trends, issues, and recent developments, including the following:

Also noted in the report are selected CAR-T therapies in development, an effort to capture current media coverage of CAR-T trials.

Key Topics Covered

1. Executive Summary

2. CAR-T Cell Therapy Market

FDA-Approved CAR-T Therapies: Yescarta and Kymriah

Recent Market Developments

Selected CAR-T Therapies in Development

CAR-T Market Analysis

3 Companies in the Market

For more information about this report visit https://www.researchandmarkets.com/r/y8awkx

View source version on businesswire.com:https://www.businesswire.com/news/home/20200131005267/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/31/2020 07:41 AM/DISC: 01/31/2020 07:41 AM